RIPK2 and inflammatory bowel disease: Thus, alterations in RIPK2 can also result in abnormal neuroinflammation and/or systemic inflammation, leading to inflammation-induced malignant changes (especially in the case of IBD/colorectal cancer and pancreatitis/pancreatic cancer).